P.53 Muscle microRNAs in the cerebrospinal fluid predict clinical response to nusinersen therapy in type II and type III spinal muscular atrophy patients

Autor: Magen, I., Aharoni, S., Yacovzada, N., Latzer, I. Tokatly, Alves, C., Sagi, L., Fattal-Valevski, A., Swoboda, K., Katz, J., Bruckheimer, E., Nevo, Y., Hornstein, E.
Zdroj: In Neuromuscular Disorders October 2022 32 Supplement 1:S62-S62
Databáze: ScienceDirect